Tags |
|
|
Links |
|
|
Digg It - The Big Mistake Companies Make In Their Training Programs
Many organizations spend huge sums of money on staff training and development and yet many times the invest
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ment does not yield the desired results.
The reason for this lack of results and what really goes wrong us
The reason for this lack of results and what really goes wrong us
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ally remains a mystery to most company executives. Especially where they have taken great care in selecting
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
a top-notch expensive training outfit to carry out their staff development program.
The wrong approach st
The wrong approach st
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
rts right from the decision-making process. Somebody in management feels that, for example, the sales team
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
is not achieving anywhere near as much sales as the competition. If there are some available figures to pro
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
e their point, the better. Naturally the first solution that comes to mind is sales training. Many times th
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
is fails miserably to have any significant effect on sales because, as is often the case, the problem is mu
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
h deeper than that.
The reason why the real cause for sales not being where they should be may never be di
The reason why the real cause for sales not being where they should be may never be di
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
scovered in such an organization is the lack of communication in the organization. One would have thought t
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
at with all the advancements in communications today, this should be a thing of the past. Alas, communicati
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ns has little to do with having access to email or personal mobile telephone numbers of all the Vice Presid
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ents of the corporation.
It has much more to do with the culture of the company and the kind of constant e
It has much more to do with the culture of the company and the kind of constant e
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
fort being made to enhance communications throughout the organization. Does the organization have a system
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
for harnessing ideas from all employees right at every level? In other words, are the channels of communica
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ion in the organization up and working? Are they a constant source of concern by senior management or do pe
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ople just think about them when there is a crisis like the example of slipping sales?
This is what makes t
This is what makes t
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
e difference. When the communication lines are truly open and working, then management has much more accura
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
te and abundant information upon which to make decisions. And even more important, training and development
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
will have the desired impact on everybody’s performance.
Copyright © 2006 Chuck Yorke - All Rights Reserve
Copyright © 2006 Chuck Yorke - All Rights Reserve
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/23131/diggit-The-Big-Mistake-Companies-Make-In-Their-Training-Programs.html">The Big Mistake Companies Make In Their Training Programs</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/23131/diggit-The-Big-Mistake-Companies-Make-In-Their-Training-Programs.html]The Big Mistake Companies Make In Their Training Programs[/url]
Related Articles:
Introduction To Online Printing Within Los Angeles
War Time Hiring: 5 Steps to Attract Top Talent
Audiobooks: How Busy Entrepreneurs Save Time
Bookmark it:
|